http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101937435-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7012 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7012 |
filingDate | 2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101937435-B1 |
titleOfInvention | glycyrrhizic acid and use thereof |
abstract | The present invention relates to a pharmaceutical composition for the prevention or treatment of neuromyelitis optica (NMO), which comprises glycyrrhizic acid or a pharmaceutically acceptable salt thereof as an active ingredient, a pharmaceutical composition for preventing or ameliorating optic neuritis A food composition and a method of treating optic neuropathy comprising administering the composition to a subject. |
priorityDate | 2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.